Cuccarini, V.; Aquino, D.; Gioppo, A.; Anghileri, E.; Pellegatta, S.; Schettino, C.; Mazzi, F.; Finocchiaro, G.; Bruzzone, M.G.; Eoli, M.
Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma. J. Clin. Med. 2019, 8, 2007.
https://doi.org/10.3390/jcm8112007
AMA Style
Cuccarini V, Aquino D, Gioppo A, Anghileri E, Pellegatta S, Schettino C, Mazzi F, Finocchiaro G, Bruzzone MG, Eoli M.
Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma. Journal of Clinical Medicine. 2019; 8(11):2007.
https://doi.org/10.3390/jcm8112007
Chicago/Turabian Style
Cuccarini, Valeria, Domenico Aquino, Andrea Gioppo, Elena Anghileri, Serena Pellegatta, Carla Schettino, Federica Mazzi, Gaetano Finocchiaro, Maria Grazia Bruzzone, and Marica Eoli.
2019. "Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma" Journal of Clinical Medicine 8, no. 11: 2007.
https://doi.org/10.3390/jcm8112007
APA Style
Cuccarini, V., Aquino, D., Gioppo, A., Anghileri, E., Pellegatta, S., Schettino, C., Mazzi, F., Finocchiaro, G., Bruzzone, M. G., & Eoli, M.
(2019). Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma. Journal of Clinical Medicine, 8(11), 2007.
https://doi.org/10.3390/jcm8112007